PCOS: komplementärmedizinische Behandlungsoptionen bei Mädchen und jungen Frauen

Adams J, Lui CW, Sibbritt D, Broom A, Wardle J, Homer C, Beck S (2009) Women’s use of complementary and alternative medicine during pregnancy: a critical review of the literature. Birth 36(3):237–245

Smith CA, Bateson DJ, Weisberg E (2013) A survey describing the use of complementary therapies and medicines by women attending a family planning clinic. BMC Complement Altern Med 13:224

Sills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL (2001) Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health 1(1):3

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47

Centre for Research Excellence in Polycystic Ovary Syndrome (2018) International evidence-based guideline for the assessment and management of polycystic ovary syndrome. Monash University, Melbourne

Ibáñez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Garcia Rudaz C, Hoeger KM, López-Bermejo A, Ong K, Peña AS, Reinehr T, Santoro N, Tena-Sempere M, Tao R, Yildiz BO, Alkhayyat H, Deeb A, Joel D, Horikawa R, de Zegher F, Lee PA (2017) An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr 88(6):371–395. https://doi.org/10.1159/000479371

Dokras A, Stener-Victorin E, Yildiz BO, Li R, Ottey S, Shah D, Epperson N, Teede H (2018) Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril 109(5):888–899

Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, Mulgrew NC, Shepherd KE, Wilkinson VH, Singh M, Balen A, Lashen H, Ledger WL (2004) The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation. Hum Reprod 19(2):371–377

Behboodi Moghadam Z, Fereidooni B, Saffari M, Montazeri A (2018) Measures of health-related quality of life in PCOS women: a systematic review. Int J Womens Health 10:397–408

Arentz S, Smith CA, Abbott JA, Bensoussan A (2014) A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome. BMC Complement Altern Med 14:472

Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R (2019) A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru 27(2):863–877

Jarry H, Spengler B, Wuttke W, Christoffel V (2006) In vitro assays for bioactivity guided isolation of endocrine active compounds in Vitex agnus-castus. Maturitas 55:S26–S36

Jarry H, Leonhardt S, Gorkow C, Wuttke W (2009) In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol Diabetes 102(06):448–454

Meier B, Berger D, Hoberg E, Sticher O, Schaffner W (2000) Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 7(5):373–381

Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R (1993) Agnus-castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 25(5):253–255

Gerhard II, Patek A, Monga B, Blank A, Gorkow C (1998) Mastodynon® bei weiblicher Sterilität. Forsch Komplementarmed 5(6):272–278

Bergmann J, Luft B, Boehmann S, Runnebaum B, Gerhard I (2000) Die Wirksamkeit des Komplexmittels Phyto-Hypophyson L bei weiblicher, hormonell bedingter Sterilität. Forsch Komplementarmed Klass Naturheilkd 7(4):190–199

Kilicdag E, Tarim E, Bagis T, Erkanli S, Aslan E, Ozsahin K, Kuscu E (2004) Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynecol Obstet 85(3):292–293

Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H (1993) Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 43(7):752–756

Fan CW, Cieri-Hutcherson NE, Hutcherson TC (2021) Systematic review of black cohosh (Cimicifuga racemosa) for management of polycystic ovary syndrome-related infertility. J Pharm Pract 29:8971900211012244

Tabakova P, Dimitrov M, Tashkov B (1984) Clinical studies on the preparation Tribestan in women with endocrine infertility or menopausal syndrome. 1st Obstetrical and Gynecological Hospital, Sofia

Dehghan A, Esfandiari A, Bigdeli SM (2012) Alternative treatment of ovarian cysts with Tribulus terrestris extract: a rat model. Reprod Domest Anim 47(1):e12–e15

Esfandiari A, Dehghan A, Sharifi S, Najafi B, Vesali E (2011) Effect of Tribulus terrestris extract on ovarian activity in immature Wistar rat: a histological evaluation. J Anim Vet Adv 10(7):883–886

Armanini D, Mattarello MJ, Fiore C, Bonanni G, Scaroni C, Sartorato P, Palermo M (2004) Licorice reduces serum testosterone in healthy women. Steroids 69(11–12):763–766

Armanini D, Castello R, Scaroni C, Bonanni G, Faccini G, Pellati D, Bertoldo A, Fiore C, Moghetti P (2007) Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 131(1):61–67

Arentz S, Smith CA, Abbott J, Fahey P, Cheema BS, Bensoussan A (2017) Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial. Phytother Res 31(9):1330–1340

Gaster B, Holroyd J (2000) St John’s wort for depression: a systematic review. Arch Intern Med 160(2):152–156

Rondanelli M, Infantino V, Riva A, Petrangolini G, Faliva MA, Peroni G, Naso M, Nichetti M, Spadaccini D, Gasparri C, Perna S (2020) Polycystic ovary syndrome management: a review of the possible amazing role of berberine. Arch Gynecol Obstet 301(1):53–60

Banaszewska B, Wrotyńska-Barczyńska J, Spaczynski RZ, Pawelczyk L, Duleba AJ (2016) Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 101(11):4322–4328

Wu D, Kimura F, Takashima A, Shimizu Y, Takebayashi A, Kita N, Zhang G, Murakami T (2013) Intake of vinegar beverage is associated with restoration of ovulatory function in women with polycystic ovary syndrome. Tohoku J Exp Med 230(1):17–23

Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S (2018) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG 125(3):299–308

Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F (2016) Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials. Int J Endocrinol 2016:1849162

Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M (2019) Metabolomic change due to combined treatment with myo-inositol, D‑chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. J Ovarian Res 12(1):25